Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme

BACKGROUND: Glioblastoma (GBM) is the most common and lethal primary malignant glioma in adults. Dendritic cell (DC) vaccines have demonstrated promising results in GBM clinical trials. However, some patients do not respond well to DC therapy, with survival rates similar to those of conventional the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Immunol
Hauptverfasser: Jan, Chia-Ing, Tsai, Wan-Chen, Harn, Horng-Jyh, Shyu, Woei-Cherng, Liu, Ming-Chao, Lu, Hsin-Man, Chiu, Shao-Chih, Cho, Der-Yang
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2018
Schlagworte:
Immunology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992384/
https://ncbi.nlm.nih.gov/pubmed/29910795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00727
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge